Company Products (7) Management (12)
 
ADETHERAPEUTICS INC
BIOTECHGATE BY VENTURE VALUATION
Latest up-date: 25 Nov 2013
GENERAL INFORMATION
G
P
T
F
M
D
 
#19-410 Downey Road
Innovation Place Research Park
S7N4N1 Saskatoon
Canada, Saskatchewan
close
Contact person Mr. Sanj Singh, President & CEO
Company main phone +1 (306) 2615189
E-mail [available with subscription]
Website www.adetherapeutics.com
 
Founded (year) 2006
Source of foundation Independent foundation
   
Corporate description / mission
AdeTherapeutics is a privately-held clinical-stage drug development company developing products that deal with complications related to surgery.
State of ownership Private / independent
Headquarters Yes
CATEGORIZATION
G
P
T
F
M
D
 
Main sector Biotechnology - Therapeutics and Diagnostics
Subsector(s)
 
Business model
  • In-licensing
  • R&D
Customer segments
  • Large biotech & big pharma
  • Hospitals
SUMMARY PRODUCTS / SERVICES / TECHNOLOGIES
G
P
T
F
M
D
 
No. of Biotech Products Pre-clinical Phase I Phase II Phase III On the market
  3 1 1 n/a n/a
No. of Medtech Products In development       On the market
  2       n/a
Description of products
Lead indication is in the gyne/general surgical market for the prevention of adhesion formation. The product is a therapeutic using a highly safe dipeptide which can be used in all types of surgeries and easily delivered in open and scope surgeries. Spinal surgery program has begun lead by Stanford and Cleveland Clinic trained neurosurgeon. Recently added top glaucoma surgeon to develop anti-fibrosis following ophthalmology procedures.
Special IP situation
Worldwide coverage in all major markets
COLLABORATIONS & CLIENTS
G
P
T
F
M
D
 
Partnering strategy / collaborations
Looking to exit after phase II trials...three additional products uses same technology platform and different formulations for separate indications
KEY
G
General profile
P
Products
T
Technologies
F
Financing rounds
M
Management
D
Deals
 
 
Click here to update this profile >>
© 2014 Venture Valuation  |  Impressum  |  Terms of Use & Privacy Policy  |  Print